MCCARTHY-KRAUSE-ERWIN-LYONS,EILEEN-KOSEL, GARRETT, CURRIE,
BRADLEY, CROTTY, GASH, DART, LANG, FRITCHEY,
JOHNSON,TIM, MULLIGAN, BROSNAHAN, RONEN, SCOTT, FRANKS AND ZICKUS.
INS HMOS-CANCER RESEARCH
Synopsis of Bill as introduced:
Amends the Illinois Insurance Code, Health Maintenance
Organization Act, and Voluntary Health Services Plans Act. Provides
that health benefit coverage under those Acts must include coverage
for patient care provided pursuant to investigational cancer
treatments. Repeals the coverage requirement January 1, 2003. Defines
terms. Effective January 1, 2000.
FISCAL NOTE (Department of Insurance)
There will be a minimal fiscal impact.
SENATE AMENDMENT NO. 1.
Deletes reference to:
215 ILCS 125/5-3
215 ILCS 165/10
Deletes all substantive provisions. Provides only a Section cap-
tion regarding insurance coverage for investigational cancer treat-
SENATE AMENDMENT NO. 2.
Adds reference to:
20 ILCS 1405/56.3 new
215 ILCS 125/5-3 from Ch. 111 1/2, par. 1411.2
215 ILCS 165/10 from Ch. 32, par. 604
Replaces everything after the enacting clause. Requires accident
and health insurance to include an offer for coverage for routine
patient care of insureds participating in approved cancer research
trials. Provides that the coverage may be limited to a $10,000
benefit per year. Requires the Department of Insurance to study the
costs and benefits resulting from the required coverage and report to
the General Assembly by March 1, 2003. Effective January 1, 2000.
SENATE AMENDMENT NO. 3.
Provides that an insurer must offer coverage for routine patient
care in connection with cancer trials rather than that a policy must
include that coverage.
Last action on Bill: PUBLIC ACT.............................. 91-0406
Last action date: 99-08-03
Amendments to Bill: AMENDMENTS ADOPTED: HOUSE - 0 SENATE - 3
END OF INQUIRY
Full Text Bill Status